SOURCE: Medical News Today
DATE: March 6, 2006
EXCERPT: Coronary artery disease, or CAD, claims more lives in the United States, Europe and other developed regions than any other disease. Prompted by symptoms such as chest pain, or angina, more than a half million U.S. women underwent coronary angiography to look for CAD in 2001. But for many of them, that test won't detect their heart disease, leaving them untreated and vulnerable to heart attacks. Fortunately, a new technology is now available that can show what other tests miss. more
RELATED PUBMED LINKS:
Pohost GM, Stevens SM. Noninvasive testing for women with suspected coronary artery disease. Curr Cardiol Rep. 2006 Feb;8(1):1-2. No abstract available. PMID: 16507226 [PubMed - indexed for MEDLINE]
Shaw LJ, Bairey Merz CN, Pepine CJ, Reis SE, Bittner V, Kelsey SF, Olson M, Johnson BD, Mankad S, Sharaf BL, Rogers WJ, Wessel TR, Arant CB, Pohost GM, Lerman A, Quyyumi AA, Sopko G; WISE Investigators. Insights from the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study: Part I: gender differences in traditional and novel risk factors, symptom evaluation, and gender-optimized diagnostic strategies. J Am Coll Cardiol. 2006 Feb 7;47(3 Suppl):S4-S20. Review. PMID: 16458170 [PubMed - indexed for MEDLINE]
Shaw LJ, Olson MB, Kip K, Kelsey SF, Johnson BD, Mark DB, Reis SE, Mankad S, Rogers WJ, Pohost GM, Arant CB, Wessel TR, Chaitman BR, Sopko G, Handberg E, Pepine CJ, Bairey Merz CN. The value of estimated functional capacity in estimating outcome: results from the NHBLI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study. J Am Coll Cardiol. 2006 Feb 7;47(3 Suppl):S36-43. PMID: 16458169 [PubMed - indexed for MEDLINE]
